http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101278390-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-899 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2011-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101278390-B1 |
| titleOfInvention | Pharmaceutical composition for preventing or treating diabetes, containing chaff as an active ingredient |
| abstract | The present invention relates to a pharmaceutical composition for preventing or treating diabetes containing chaff herb as an active ingredient. Specifically, chaff extract according to the present invention inhibits the production of Oxyative Reactive Species (ROS) of cells, inhibits the production of nitric oxide (NO) of cells, and tumor necrosis factor-α (Tumor Necrosis Factor). -α, TNF-α), interleukin-1β (InterLeukin-1β, IL-1β) or interleukin-6 (InterLeukin-6, IL-6) gene expression is suppressed. It also restores insulin production, suppresses blood sugar levels, increases serum insulin levels and hepatic glycogen levels, and the glucose metabolism regulating enzyme glucose-6-Phosphatase (G6Pase). ) And decreases phosphoenolpyruvate carboxykinase (PEPCK) or glucose kinase (Glucokinase, GCK), inhibiting cell death in the island of Langerhans. It is expected to be useful for preventing or treating diabetes. |
| priorityDate | 2011-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1123.